Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Landman

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Cancers|July 2, 2021
Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort StudyJing de Haan-Du, Gijs W D Landman, Nanne Kleefstra, et al.
Plos One|February 18, 2014
Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trialsGijs W D Landman, Geertruide H de Bock, Kornelis J J van Hateren, et al.
American Heart Journal|March 21, 2016
High-sensitive troponin T is associated with all-cause and cardiovascular mortality in stable outpatients with type 2 diabetes (ZODIAC-37)Steven H Hendriks, Peter R van Dijk, Kornelis J J van Hateren, et al.
Plos One|July 29, 2015
Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)Kornelis J J van Hateren, Gijs W D Landman, Jarinke F H Arnold, et al.
Cardiovascular Diabetology|November 9, 2012
Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)Gijs W D Landman, Jana V van Vliet-Ostaptchouk, Nanne Kleefstra, et al.
Diabetes Care|October 31, 2013
Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30)Gijs W D Landman, Peter R van Dijk, Iefke Drion, et al.
Diabetes Care|December 12, 2012
The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25)Kornelis J J van Hateren, Gijs W D Landman, Nanne Kleefstra, et al.
Plos One|March 4, 2014
Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28)Esther G Gerrits, Alaa Alkhalaf, Gijs W D Landman, et al.
Journal of Nephrology|April 24, 2014
Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22)A Alkhalaf, G W D Landman, K J J van Hateren, et al.
Atherosclerosis|July 23, 2015
Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46)Ineke J Riphagen, Susan J J Logtenberg, Klaas H Groenier, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Cancers|July 2, 2021
Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort StudyJing de Haan-Du, Gijs W D Landman, Nanne Kleefstra, et al.
Plos One|February 18, 2014
Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trialsGijs W D Landman, Geertruide H de Bock, Kornelis J J van Hateren, et al.
American Heart Journal|March 21, 2016
High-sensitive troponin T is associated with all-cause and cardiovascular mortality in stable outpatients with type 2 diabetes (ZODIAC-37)Steven H Hendriks, Peter R van Dijk, Kornelis J J van Hateren, et al.
Plos One|July 29, 2015
Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)Kornelis J J van Hateren, Gijs W D Landman, Jarinke F H Arnold, et al.
Cardiovascular Diabetology|November 9, 2012
Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)Gijs W D Landman, Jana V van Vliet-Ostaptchouk, Nanne Kleefstra, et al.
Diabetes Care|October 31, 2013
Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30)Gijs W D Landman, Peter R van Dijk, Iefke Drion, et al.
Diabetes Care|December 12, 2012
The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25)Kornelis J J van Hateren, Gijs W D Landman, Nanne Kleefstra, et al.
Plos One|March 4, 2014
Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28)Esther G Gerrits, Alaa Alkhalaf, Gijs W D Landman, et al.
Journal of Nephrology|April 24, 2014
Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22)A Alkhalaf, G W D Landman, K J J van Hateren, et al.
Atherosclerosis|July 23, 2015
Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46)Ineke J Riphagen, Susan J J Logtenberg, Klaas H Groenier, et al.
Pageof 14